REP. ONDER INTRODUCES THE ALLERGY AND ASTHMA PATIENT PROTECTION ACT
The following information was released by the office of MissouriRep.
Today,
"Patients shouldn't have to fight their insurance company to get medically necessary allergy and asthma care. As an allergist, I've witnessed insurers deny the buildup phase of allergy shots, cap the number of allergens that can be tested, and impose paperwork that has nothing to do with good medicine. My bill protects access to diagnostic testing and ensures patients covered for allergy shots receive every medically necessary phase of treatment. Coverage decisions should follow the clinical standards physicians use, not arbitrary rules set by insurance companies," said Congressman
"For families dealing with allergies and asthma, timely testing and effective treatment can make a tremendous difference in their quality of life," said
"
"Millions of Americans who rely on essential asthma testing and allergy immunotherapy face unfair insurance hurdles, arbitrary coverage limits, and out-of-pocket delays just to get the care their doctors prescribe. The Allergy and Asthma Patient Protection Act guarantees that private health plans cover medically necessary diagnostic testing and every stage of immunotherapy treatment. This bill ensures that care is dictated by clinical science, not administrative interference. It would protect patient access to proven treatments that can help manage disease, so children can stay in school, parents can go to work, and families can stay healthy." -
"For more than a century, allergy shots have helped patients take control of their allergic disease. Insurers shouldn't be allowed to undercut that care with arbitrary restrictions that ignore clinical standards and physician decision making. The Allergy and Asthma Patient Protection Act ensures that care decisions related to testing and treatment stay between patients and their physician," said
"Every patient deserves a treatment plan tailored by their clinician, not dictated by an insurer parsing their coverage arbitrarily. When insurers step outside their role as a payer to restrict testing or underfund essential treatments, patients are the ones who suffer. Decisions around testing and immunotherapy must remain between a patient and their clinician, free from arbitrary coverage denials and payment cuts. By passing the Allergy and Asthma Patient Protection Act,
"The allergy season is longer and more intense, and for people with allergic asthma, allergies can trigger asthma attacks. Between 9-11 Americans die from asthma every day.
"
"No Nut Traveler supports the Allergy and Asthma Patient Protection Act because it would put clinical standards at the center of coverage decisions, from the tests that help diagnose allergies and asthma to the care patients need once they have answers. Families deserve to spend less time sorting out coverage and more time getting the care that helps them sleep, learn, work, and enjoy their lives."
"Patients living with allergies and asthma deserve access to timely, accurate testing and medically necessary treatment without unnecessary barriers imposed by insurance companies. The Allergy and Asthma Patient Protection Act addresses these challenges by protecting access to essential diagnostic testing and allergen immunotherapy. Families should never have to choose between their financial well-being and receiving appropriate medical care. As an advocate for allergy and asthma patient safety, I strongly support this legislation and its commitment to ensuring that treatment decisions are guided by established clinical standards, not arbitrary insurance restrictions. Access to care should be a right, not a barrier patients must fight to overcome." -
"Ignoring a health issue is the best way to ensure poor outcomes and maximum cost to treat that very issue. The Allergy and Asthma Patient Protection Act embraces the power of diagnostics and preventative care for those who need it most.
"Effective and appropriate treatment begins with accurate diagnosis. Diagnostic decisions made between a doctor and their patients are critical decision points, ensuring neither patients nor the healthcare system is burdened by overdiagnosis, underdiagnosis, or misdiagnosis. Limits to effective diagnosis and appropriate treatment result in physical, financial, psychological strain for patients, as well as additional health risks that can complicate and compound future health decisions. Support for the Allergy and Asthma Patient Protection Act aligns coverage with clinical practice, improving the lives of patients and their families while employing a forward-thinking strategy for insurers and the healthcare system as a whole."
Background Information
Allergen immunotherapy (allergy shots) has been used successfully for more than 110 years to treat patients with environmental allergies. Patients receive gradually increasing doses of allergen by injection, starting with a buildup phase and eventually reaching a maintenance dose. It is a cost-effective, disease-modifying treatment that changes the course of allergic disease rather than managing symptoms. Yet a growing number of insurers are adopting billing and coverage policies that make it harder for patients to access this important treatment.
Some insurers are:
Refusing to cover the buildup phase of immunotherapy (the period when a patient's dose is gradually increased)
Imposing arbitrary unit and volume limits on allergy shots that fall well below clinical standards
Capping the number of allergens that can be tested, or denying testing done on the same day as an office visit
Reducing payment for extracts that contain diluent, a standard part of preparing nearly every allergy shot
Denying claims when a patient's extract must be split into multiple vials for safety or potency
These policies have no clinical justification and contradict the practice standards established by medical specialty societies that treat allergic conditions. They are administrative barriers that shift costs onto patients and the physicians who treat them.
WHAT THE ALLERGY and ASTHMA PATIENT PROTECTION ACT DOES:
Requires coverage of allergy and asthma diagnostic testing in private health insurance, without arbitrary limits that conflict with clinical standards
Protects allergy shot coverage by requiring plans that cover immunotherapy to pay for extract preparation and every medically necessary phase of treatment
Ties coverage to the clinical standards physicians already follow, the practice parameters published by the national allergy and immunology specialty societies and CPT code descriptions


NAIFA applauds final SECURE 2.0 regulations
Advisor News
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
More Advisor NewsAnnuity News
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity NewsHealth/Employee Benefits News
- REP. ONDER INTRODUCES THE ALLERGY AND ASTHMA PATIENT PROTECTION ACT
- Forms, phone calls and portals: The hidden work that keeps American institutions functioning burdens parents most
- What will Democrats in Congress do about healthcare and retirement?
- Forms, phone calls and portals: The hidden work that keeps American institutions functioning burdens parents most
- Health Plans Expect Double-Digit Premium Increases Again in 2027
More Health/Employee Benefits NewsLife Insurance News
- California’s new solvency rules: What should life insurance advisors watch?
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
- AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
More Life Insurance News